COLLEGIUM PHARMACEUTICAL INC's ticker is and the CUSIP is 19459JAA2. A total of 19 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,185 | -99.9% | 46,945,000 | -9.6% | 1.24% | +95.9% |
| Q3 2022 | $45,236,000 | +4.8% | 51,945,000 | 0.0% | 0.64% | -35.5% |
| Q2 2022 | $43,179,000 | +43.5% | 51,945,000 | +62.6% | 0.98% | +40.6% |
| Q1 2022 | $30,087,000 | -2.7% | 31,945,000 | 0.0% | 0.70% | +3.7% |
| Q4 2021 | $30,907,000 | -17.6% | 31,945,000 | -14.2% | 0.68% | -31.9% |
| Q3 2021 | $37,506,000 | -5.8% | 37,245,000 | +5.7% | 0.99% | -10.2% |
| Q2 2021 | $39,802,000 | +19.6% | 35,245,000 | +16.5% | 1.10% | -16.9% |
| Q1 2021 | $33,292,000 | -4.8% | 30,245,000 | -16.0% | 1.33% | -0.9% |
| Q4 2020 | $34,967,000 | +11.7% | 35,995,000 | +10.8% | 1.34% | -20.7% |
| Q3 2020 | $31,313,000 | +444.6% | 32,495,000 | +407.7% | 1.69% | +245.2% |
| Q2 2020 | $5,750,000 | +0.5% | 6,400,000 | -1.5% | 0.49% | -20.1% |
| Q1 2020 | $5,720,000 | – | 6,500,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 9,500,000 | $89,474,000 | 1.79% |
| STEELHEAD PARTNERS LLC | 15,500,000 | $15,458,000 | 1.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,945,000 | $30,087,000 | 0.70% |
| DeepCurrents Investment Group LLC | 18,059,000 | $17,964,000 | 0.56% |
| Context Capital Management, LLC | 6,000 | $5,947,000 | 0.39% |
| AQR Arbitrage LLC | 9,975,000 | $9,970,000 | 0.26% |
| LINDEN ADVISORS LP | 11,825,000 | $11,659,000 | 0.07% |
| Verition Fund Management LLC | 5,069,000 | $5,066,000 | 0.06% |
| LAZARD ASSET MANAGEMENT LLC | 27,800,000 | $27,786,000 | 0.03% |
| Calamos Advisors LLC | 3,500,000 | $3,491,000 | 0.01% |